Sentinel node biopsy and survival in cutaneous melanoma: a nationwide population-based cohort study

This publication has 41 references indexed in Scilit:

• Predictive performance of the clinicopathologic gene expression profile (CP-GEP) in identifying cutaneous melanoma patients for whom sentinel lymph node biopsy is unnecessary: A systematic review and meta-analysis
  Critical Reviews in Oncology/Hematology, 2025
• Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma
  JAMA Dermatology, 2025
• Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma
  Annals of Oncology, 2025
• Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  Annals of Oncology, 2024
• Stage-Specific Risk of Recurrence and Death From Melanoma in Denmark, 2008-2021
  JAMA Dermatology, 2023
• The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients
  Cancer Epidemiology, 2021
• On the estimation of average treatment effects with right‐censored time to event outcome and competing risks
  Biometrical Journal, 2020
• The real-world impact of modern treatments on the survival of patients with metastatic melanoma
  European Journal of Cancer, 2019
• Sentinel node biopsy in melanoma: Current controversies addressed
  European Journal of Surgical Oncology, 2017
• A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
  Journal of Chronic Diseases, 1987